# Astrocyte Pharmaceuticals funding rounds and investors

As of 22 Nov 2026, Astrocyte Pharmaceuticals has raised $9.5M across 1 verified round on record, plus 3 rounds still being checked; latest: $9.5M Series B led by DeepWork Capital, announced 30 Sep 2026.

A clinical-stage biotechnology company developing first-in-class cerebroprotective therapies for concussion, traumatic brain injury (TBI) and stroke

Website: https://www.astrocytepharma.com/  
Headquarters: Groton, CT  
Page: https://fireround.dev/companies/astrocyte-pharmaceuticals

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-09-30 | Series B | $9.5M | DeepWork Capital | MintPharma Capital, Waterstar Capital, Dynagrow Capital, Angel Star Ventures | [astrocytepharma.com](https://www.astrocytepharma.com/2026/09/astrocyte-secures-9-5-m-series-b), [prnewswire.com](https://www.prnewswire.com/news-releases/astrocyte-pharmaceuticals-secures-9-5-million-series-b-to-advance-phase-2-clinical-development-of-breakthrough-tbi-and-concussion-therapy-ast-004--302893833.html), [biospace.com](https://www.biospace.com/press-releases/astrocyte-pharmaceuticals-secures-9-5-million-series-b-to-advance-phase-2-clinical-development-of-breakthrough-tbi-and-concussion-therapy-ast-004) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.
